Report Detail

Request for Sample of this report

Other Global Diabetic Nephropathy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4597321
    • |
  • 02 July, 2024
    • |
  • Global
    • |
  • 109 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Diabetic Nephropathy market size was valued at USD 2517.6 million in 2023 and is forecast to a readjusted size of USD 3447.6 million by 2030 with a CAGR of 4.6% during review period.
Diabetic nephropathy is a disease of the kidney glomerulus and one of the most significant complications in terms of mortality and morbidity for patients with diabetes. Diabetic nephropathy is mainly characterized by macroalbuminuria. The presence of over 300 milligrams of albumin in the urine in 1 day is known as macroalbuminuria. Globally, the diabetic nephropathy market is witnessing significant growth due to rise in the incidence of diabetes and obesity in different regions of the world. In addition, increasing R&D investments in drug discovery and development by various companies, such as Sanofi, Eli Lilly and Mitsubishi Tanabe Pharma is also driving the growth of the market.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
The Global Info Research report includes an overview of the development of the Diabetic Nephropathy industry chain, the market status of Hospitals (ACE Inhibitors, ARBs), Cancer Research Institutes (ACE Inhibitors, ARBs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Diabetic Nephropathy.
Regionally, the report analyzes the Diabetic Nephropathy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Diabetic Nephropathy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Diabetic Nephropathy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Diabetic Nephropathy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., ACE Inhibitors, ARBs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Diabetic Nephropathy market.
Regional Analysis: The report involves examining the Diabetic Nephropathy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Diabetic Nephropathy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Diabetic Nephropathy:
Company Analysis: Report covers individual Diabetic Nephropathy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Diabetic Nephropathy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Cancer Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Diabetic Nephropathy. It assesses the current state, advancements, and potential future developments in Diabetic Nephropathy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Diabetic Nephropathy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Diabetic Nephropathy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
ACE Inhibitors
ARBs
Diuretics
Calcium Channel Blockers(CCBs)
Renin Inhibitors
Connective Tissue Growth Factor (CTGF) Inhibitors
Antioxidant Inflammation Modulators(AIMs)
Monocyte Chemoattractant Protein (MCP)Inhibitors
Endothelin-A Receptor(ETAR)Antagonist
G Protein-Coupled Receptors (GPCRs)
Market segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
Market segment by players, this report covers
Novartis
Merck
Pfizer
Abbott Laboratories
Sanofi
Eli Lilly
AbbVie
Reata Pharmaceuticals
Bayer
Mitsubishi Tanabe Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diabetic Nephropathy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diabetic Nephropathy, with revenue, gross margin and global market share of Diabetic Nephropathy from 2019 to 2024.
Chapter 3, the Diabetic Nephropathy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Diabetic Nephropathy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetic Nephropathy.
Chapter 13, to describe Diabetic Nephropathy research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Diabetic Nephropathy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Diabetic Nephropathy by Type
    • 1.3.1 Overview: Global Diabetic Nephropathy Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Diabetic Nephropathy Consumption Value Market Share by Type in 2023
    • 1.3.3 ACE Inhibitors
    • 1.3.4 ARBs
    • 1.3.5 Diuretics
    • 1.3.6 Calcium Channel Blockers(CCBs)
    • 1.3.7 Renin Inhibitors
    • 1.3.8 Connective Tissue Growth Factor (CTGF) Inhibitors
    • 1.3.9 Antioxidant Inflammation Modulators(AIMs)
    • 1.3.10 Monocyte Chemoattractant Protein (MCP)Inhibitors
    • 1.3.11 Endothelin-A Receptor(ETAR)Antagonist
    • 1.3.12 G Protein-Coupled Receptors (GPCRs)
  • 1.4 Global Diabetic Nephropathy Market by Application
    • 1.4.1 Overview: Global Diabetic Nephropathy Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Cancer Research Institutes
    • 1.4.4 Diagnostic Labs
  • 1.5 Global Diabetic Nephropathy Market Size & Forecast
  • 1.6 Global Diabetic Nephropathy Market Size and Forecast by Region
    • 1.6.1 Global Diabetic Nephropathy Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Diabetic Nephropathy Market Size by Region, (2019-2030)
    • 1.6.3 North America Diabetic Nephropathy Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Diabetic Nephropathy Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Diabetic Nephropathy Market Size and Prospect (2019-2030)
    • 1.6.6 South America Diabetic Nephropathy Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Diabetic Nephropathy Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Diabetic Nephropathy Product and Solutions
    • 2.1.4 Novartis Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Novartis Recent Developments and Future Plans
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Diabetic Nephropathy Product and Solutions
    • 2.2.4 Merck Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Merck Recent Developments and Future Plans
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Diabetic Nephropathy Product and Solutions
    • 2.3.4 Pfizer Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Pfizer Recent Developments and Future Plans
  • 2.4 Abbott Laboratories
    • 2.4.1 Abbott Laboratories Details
    • 2.4.2 Abbott Laboratories Major Business
    • 2.4.3 Abbott Laboratories Diabetic Nephropathy Product and Solutions
    • 2.4.4 Abbott Laboratories Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi Diabetic Nephropathy Product and Solutions
    • 2.5.4 Sanofi Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sanofi Recent Developments and Future Plans
  • 2.6 Eli Lilly
    • 2.6.1 Eli Lilly Details
    • 2.6.2 Eli Lilly Major Business
    • 2.6.3 Eli Lilly Diabetic Nephropathy Product and Solutions
    • 2.6.4 Eli Lilly Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Eli Lilly Recent Developments and Future Plans
  • 2.7 AbbVie
    • 2.7.1 AbbVie Details
    • 2.7.2 AbbVie Major Business
    • 2.7.3 AbbVie Diabetic Nephropathy Product and Solutions
    • 2.7.4 AbbVie Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 AbbVie Recent Developments and Future Plans
  • 2.8 Reata Pharmaceuticals
    • 2.8.1 Reata Pharmaceuticals Details
    • 2.8.2 Reata Pharmaceuticals Major Business
    • 2.8.3 Reata Pharmaceuticals Diabetic Nephropathy Product and Solutions
    • 2.8.4 Reata Pharmaceuticals Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Reata Pharmaceuticals Recent Developments and Future Plans
  • 2.9 Bayer
    • 2.9.1 Bayer Details
    • 2.9.2 Bayer Major Business
    • 2.9.3 Bayer Diabetic Nephropathy Product and Solutions
    • 2.9.4 Bayer Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bayer Recent Developments and Future Plans
  • 2.10 Mitsubishi Tanabe Pharma
    • 2.10.1 Mitsubishi Tanabe Pharma Details
    • 2.10.2 Mitsubishi Tanabe Pharma Major Business
    • 2.10.3 Mitsubishi Tanabe Pharma Diabetic Nephropathy Product and Solutions
    • 2.10.4 Mitsubishi Tanabe Pharma Diabetic Nephropathy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Diabetic Nephropathy Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Diabetic Nephropathy by Company Revenue
    • 3.2.2 Top 3 Diabetic Nephropathy Players Market Share in 2023
    • 3.2.3 Top 6 Diabetic Nephropathy Players Market Share in 2023
  • 3.3 Diabetic Nephropathy Market: Overall Company Footprint Analysis
    • 3.3.1 Diabetic Nephropathy Market: Region Footprint
    • 3.3.2 Diabetic Nephropathy Market: Company Product Type Footprint
    • 3.3.3 Diabetic Nephropathy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Diabetic Nephropathy Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Diabetic Nephropathy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Diabetic Nephropathy Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Diabetic Nephropathy Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Diabetic Nephropathy Consumption Value by Type (2019-2030)
  • 6.2 North America Diabetic Nephropathy Consumption Value by Application (2019-2030)
  • 6.3 North America Diabetic Nephropathy Market Size by Country
    • 6.3.1 North America Diabetic Nephropathy Consumption Value by Country (2019-2030)
    • 6.3.2 United States Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Diabetic Nephropathy Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Diabetic Nephropathy Consumption Value by Type (2019-2030)
  • 7.2 Europe Diabetic Nephropathy Consumption Value by Application (2019-2030)
  • 7.3 Europe Diabetic Nephropathy Market Size by Country
    • 7.3.1 Europe Diabetic Nephropathy Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 7.3.3 France Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Diabetic Nephropathy Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Diabetic Nephropathy Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Diabetic Nephropathy Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Diabetic Nephropathy Market Size by Region
    • 8.3.1 Asia-Pacific Diabetic Nephropathy Consumption Value by Region (2019-2030)
    • 8.3.2 China Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 8.3.5 India Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Diabetic Nephropathy Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Diabetic Nephropathy Consumption Value by Type (2019-2030)
  • 9.2 South America Diabetic Nephropathy Consumption Value by Application (2019-2030)
  • 9.3 South America Diabetic Nephropathy Market Size by Country
    • 9.3.1 South America Diabetic Nephropathy Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Diabetic Nephropathy Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Diabetic Nephropathy Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Diabetic Nephropathy Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Diabetic Nephropathy Market Size by Country
    • 10.3.1 Middle East & Africa Diabetic Nephropathy Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Diabetic Nephropathy Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Diabetic Nephropathy Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Diabetic Nephropathy Market Drivers
  • 11.2 Diabetic Nephropathy Market Restraints
  • 11.3 Diabetic Nephropathy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Diabetic Nephropathy Industry Chain
  • 12.2 Diabetic Nephropathy Upstream Analysis
  • 12.3 Diabetic Nephropathy Midstream Analysis
  • 12.4 Diabetic Nephropathy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Diabetic Nephropathy. Industry analysis & Market Report on Diabetic Nephropathy is a syndicated market report, published as Global Diabetic Nephropathy Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Diabetic Nephropathy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo